Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor

New England Journal of Medicine

Volumn 351, Issue 4, 2004, Pages 362-369

  Pallais, J Carl ^a   Kifor, Olga ^b   Chen, Yi Bin ^a   Slovik, David ^a   Brown, Edward M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM; CALCIUM SENSING RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G4 AUTOANTIBODY; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; PREDNISONE; UNCLASSIFIED DRUG;

ACQUIRED HYPOCALCIURIC HYPERCALCEMIA; AGED; ARTICLE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRATION; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCIURIA; PARATHYROIDECTOMY; PEMPHIGOID; PRIORITY JOURNAL;

AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CALCIUM; CELL LINE; CREATININE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMUNOGLOBULIN G; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; RECEPTORS, CALCIUM-SENSING;

EID: 3242657067     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa040008     Document Type: Article

References (23)

1. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: W.B. Saunders, 2003:1303-71.
2. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863-75.
3. Yoshimoto K, Yamasaki R, Sakai H, et al. Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 1989;68:976-81.
4. Nussbaum SR, Gaz RD, Arnold A. Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 1990;323:1324-8.
5. S. Heath H III. Familial benign (hypocalciuric) hypercalcemia: a troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am 1989;18:723-40.
6. Brown EM. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinol Metab Clin North Am 2000;29:503-22.
7. Attie MF, Gill JR Jr, Stock JL, et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia: persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 1983;72:667-76.
8. Hebert SC, Brown EM, Harris HW. Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997;200:295-302.
9. Kifor O, Moore FD Jr, Delaney M, et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 2003;88:60-72.
10. Kifor O, Diaz R, Butters R, Brown EM. The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 1997;12:715-25.
11. Marx SJ, Attie MF, Spiegel AM, Levine MA, Lasker RD, Fox M. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 1982;306:257-64.
12. Marx SJ, Stock JL, Attie MF, et al. Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med 1980;92:351-6.
13. Foley TP Jr, Harrison HC, Arnaud CD, Harrison HE. Familial benign hypercalcemia. J Pediatr 1972;81:1060-7.
14. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 1993;82:1383-94.
15. Sandler LM, Winearls CG, Fraher LJ, Clemens TL, Smith R, O'Riordan JL. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. QJ Med 1984;53:165-80.
16. Dent CE, Watson L. The hydrocortisone test in primary and tertiary hyperparathyroidism. Lancet 1968;2:6624.
17. Li Y, Song YH, Rais N, et al. Autoantibodies to the extracellular domain of the calcium-sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996;97:910-4.
18. Brandi ML, Aurbach GD, Fattorossi A, Quarto R, Marx SJ, Fitzpatrick LA. Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A 1986;83:8366-9.
19. Fattorossi A, Aurbach GD, Sakaguchi K, et al. Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A 1988;85:4015-9.
20. Hofmann S, Thoma-Uszynski S, Hunziker T, et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002;119:1065-73.
21. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
22. Jefferis R, Pound J, Lund J, Goodall M. Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Ann Biol Clin (Paris) 1994;52:57-65.
23. Shobaek DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003;88:5644-9.